Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-CD25/IL-2Rα Antibody (7G7B6) is a murine chimeric antibody specifically targeting human CD25/IL-2Rα, which exerts tumor growth inhibitory activity and can be used as a research tool in the field of leukemia-related studies.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $245 | 4-6 weeks | 4-6 weeks | |
| 5 mg | $535 | 4-6 weeks | 4-6 weeks | |
| 10 mg | Preferential | 4-6 weeks | 4-6 weeks |
| Description | Anti-CD25/IL-2Rα Antibody (7G7B6) is a murine chimeric antibody specifically targeting human CD25/IL-2Rα, which exerts tumor growth inhibitory activity and can be used as a research tool in the field of leukemia-related studies. |
| In vivo | Intraperitoneal administration of Anti-CD25/IL-2Rα Antibody (7G7B6) (200 μg per dose, administered on days 11, 13, 15 and 17) exerted a significant inhibitory effect on tumor growth in RAG-1⁻/⁻ SIRPα double knockout (DKO) mice bearing L1210 tumors [1]. |
| Clone | 7G7B6 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CD25/IL-2Rα |
| Molecular Weight | 150 kDa |
| Isotype | Mouse IgG2a |
| Recommended Isotype Control |
| Storage | Lyophilized powder: -20~-80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.